Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 or older
- People who have been diagnosed with a pulmonary embolism (a blood clot in the lungs) within the last 24 hours, confirmed by medical testing, where the clot is not causing dangerous instability in the body
- People who have an active cancer (other than certain common skin cancers), meaning the cancer was diagnosed in the past 6 months, is currently being treated or was treated in the past 6 months, or has spread or come back
- People who do not have other serious medical conditions beyond their cancer that would normally require hospital admission (a specific medical checklist called HESTIA is used to assess this)
- Women who could potentially become pregnant must have a negative pregnancy test before joining
- People who have read and signed a consent form agreeing to take part
- People enrolled in the French social security system
- People with a good understanding of the French language
Who may not be able to join:
- People whose pulmonary embolism was diagnosed more than 24 hours before the time of enrolment
- People experiencing a serious drop in blood pressure (a sign the body is in shock), unless caused by specific other medical reasons
- People who have already been in hospital for more than 24 hours
- People whose cancer or overall health has severely limited their ability to carry out basic daily activities (based on a standard medical scale, levels 3 or 4 out of 4)
- People for whom a 30-day follow-up appointment would not be possible
- People whose life expectancy is estimated to be less than 30 days
- People who are currently detained under a judicial or administrative order
- People who are under a legal protection measure (such as a court-appointed guardian) (confirm with trial site)
- People who are not able to give free and fully informed consent
- People already participating in another interventional clinical study that requires hospitalisation
- Women who are pregnant or breastfeeding
- People receiving AME (a specific French state medical aid programme for those without standard social security coverage)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Olivier SANCHEZ, MD, Assistance Publique - Hôpitaux de Paris
Phone: +33156095638
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Rate of composite primary endpoint
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.